Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenue
Revenue	$ 12,241	$ 11,102	$ 9,917
Costs and expenses:
Cost of revenue	2,086	1,878	1,703
Operations and support	1,327	1,282	1,186
Product development	2,354	2,056	1,722
Sales and marketing	2,588	2,148	1,763
General and administrative	1,342	1,185	2,025
Total costs and expenses	9,697	8,549	8,399
Income from operations	2,544	2,553	1,518
Interest income	705	818	721
Other expense, net	(112)	(40)	(137)
Income before income taxes	3,137	3,331	2,102
Provision for (benefit from) income taxes	626	683	(2,690)
Net income	$ 2,511	$ 2,648	$ 4,792
Net income per share attributable to Class A and Class B common stockholders:
Basic (in USD per share)	$ 4.10	$ 4.19	$ 7.52
Diluted (in USD per share)	$ 4.03	$ 4.11	$ 7.24
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic (in shares)	613	632	637
Diluted (in Shares)	623	645	662

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 2,511	$ 2,648	$ 4,792
Adjustments to reconcile net income to cash provided by operating activities:
Stock-based compensation expense	1,592	1,407	1,120
Deferred income taxes	376	433	(2,875)
Other, net	273	97	127
Changes in operating assets and liabilities, net of acquisitions:
Prepaids and other assets	(346)	(163)	(102)
Accrued expenses and other liabilities	118	(104)	580
Unearned fees	122	200	242
Net cash provided by operating activities	4,646	4,518	3,884
Cash flows from investing activities:
Purchases of short-term investments	(3,438)	(3,146)	(3,308)
Sales and maturities of short-term investments	2,736	2,605	2,380
Other investing activities, net	(46)	(75)	(114)
Net cash used in investing activities	(748)	(616)	(1,042)
Cash flows from financing activities:
Share repurchases	(3,789)	(3,430)	(2,252)
Taxes paid related to tax on equity awards	(561)	(630)	(1,224)
Change in funds payable and amounts payable to customers	401	320	936
Proceeds from exercise of equity awards and employee stock purchase plan	122	168	110
Net cash used in financing activities	(3,827)	(3,572)	(2,430)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	655	(237)	152
Net increase in cash, cash equivalents, and restricted cash	726	93	564
Cash, cash equivalents, and restricted cash, beginning of year	12,760	12,667	12,103
Cash, cash equivalents, and restricted cash, end of year	$ 13,486	$ 12,760	$ 12,667

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 6,560	$ 6,864
Short-term investments	4,454	3,747
Funds receivable and amounts held on behalf of customers	6,959	5,931
Prepaids and other current assets	824	638
Total current assets	18,797	17,180
Deferred income tax assets	2,102	2,439
Goodwill and intangible assets, net	770	777
Other assets, noncurrent	539	563
Total assets	22,208	20,959
Current liabilities:
Accrued expenses, accounts payable, and other current liabilities	2,948	2,614
Funds payable and amounts payable to customers	6,959	5,931
Current portion of long-term debt	1,999	0
Unearned fees	1,743	1,616
Total current liabilities	13,649	10,161
Long-term debt	0	1,995
Other liabilities, noncurrent	360	391
Total liabilities	14,009	12,547
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock	0	0
Additional paid-in capital	13,763	12,602
Accumulated other comprehensive income (loss)	(62)	35
Accumulated deficit	(5,502)	(4,225)
Total stockholders’ equity	8,199	8,412
Total liabilities and stockholders’ equity	$ 22,208	$ 20,959